Stock Volatility
搜索文档
Rocket Lab Stock Surges on Revenue Win, $30M Contract
Schaeffers Investment Research· 2026-05-08 22:11
Drilling down to today's options activity, 76,000 calls and 33,000 puts have traded hands, which is seven times the amount typically seen at this point. Most active by far is the June 75 put, followed by the 90 put in that series, with new positions being opened at the latter. The stock's Schaeffer's Volatility Scorecard (SVS) comes in at 84 out of 100. In other words, shares have consistently realized higher volatility than its options have priced in over the past 12 months. The shares of Rocket Lab Corp ( ...
2 Trendlines in Focus For Pfizer Stock After Earnings
Schaeffers Investment Research· 2026-05-05 22:44
公司业绩与股价表现 - 辉瑞公司2024年第一季度调整后每股收益为0.75美元,营收为1445万美元,两项数据均超出市场预期[1] - 公司重申了其2026年的业绩展望,主要得益于新产品的增长[1] - 尽管业绩超预期,公司股价在最新交易中仍下跌1.1%,报收于26.03美元,逆转了盘前涨势[1] - 今年以来,公司股价累计上涨5.8%[2] 关键技术位与交易活动 - 公司股价自2月以来一直在26美元附近获得支撑,目前正在测试该关键水平[1][2] - 上周,公司股价在收盘时首次突破了其126日移动平均线,这是今年以来的首次[2] - 从整体期权交易者情绪来看,看涨期权更受青睐:其10日看跌/看涨成交量比率为6.29,位于其年度范围的76百分位[2] - 然而,短期期权交易者正关注看跌期权:辉瑞股票的Schaeffer看跌/看涨未平仓权益比率位于年度读数的80百分位[3] - 今日期权活动尤为活跃,已有4.5万份看跌期权成交,达到此时段通常成交量的四倍,其中最活跃的合约为6月24日到期的看跌期权,且观察到新的开仓买入[3] 波动性特征 - 辉瑞的Schaeffer波动性评分仅为6分(满分100分),表明在过去12个月中,其股票实际实现的波动性持续低于其期权定价所隐含的波动性[4] - 基于此低波动性评分,该股票被视为出售期权溢价(即做空波动性)的潜在候选标的[4]